Study of the Effects of Betaine and/or C-Phycocyanin on the Growth of Lung Cancer A549 CellsIn VitroandIn Vivo

Author:

Bingula Rea1ORCID,Dupuis Carmen1ORCID,Pichon Chantal2,Berthon Jean-Yves3ORCID,Filaire Marc14ORCID,Pigeon Lucie2,Filaire Edith156ORCID

Affiliation:

1. Unité Mixte de Recherche 1019, Centre de Recherche en Nutrition Humaine Auvergne, Université d’Auvergne, 63000 Clermont-Ferrand, France

2. CNRS UPR4301, Université Orléans, 45100 Orléans, France

3. Greentech SA, Biopôle Clermont-Limagne, 63360 Saint-Beauzire, France

4. Centre Jean Perrin, Service de Chirurgie Thoracique, 58 rue Montalembert, 63011 Clermont-Ferrand, France

5. CIAMS, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay Cedex, France

6. CIAMS, Université d’Orléans, 45067 Orléans, France

Abstract

We investigated the effects of betaine, C-phycocyanin (C-PC), and their combined use on the growth of A549 lung cancer bothin vitroandin vivo.When cells were coincubated with betaine and C-PC, an up to 60% decrease in viability was observed which is significant compared to betaine (50%) or C-PC treatment alone (no decrease). Combined treatment reduced the stimulation of NF-κB expression by TNF-αand increased the amount of the proapoptotic p38 MAPK. Interestingly, combined treatment induced a cell cycle arrest in G2/M phase for ~60% of cells.In vivostudies were performed in pathogen-free male nude rats injected with A549 cells in their right flank. Their daily food was supplemented with either betaine, C-PC, both, or neither. Compared to the control group, tumour weights and volumes were significantly reduced in either betaine- or C-PC-treated groups and no additional decrease was obtained with the combined treatment. This data indicates that C-PC and betaine alone may efficiently inhibit tumour growth in rats. The synergistic activity of betaine and C-PC on A549 cells growth observedin vitroremains to be further confirmedin vivo.The reason behind the nature of their interaction is yet to be sought.

Funder

Ligue Contre le Cancer

Publisher

Hindawi Limited

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3